Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Jens Ulrik Jensen"'
Autor:
Pradeesh Sivapalan, Valdemar Rømer, Tobias Wirenfeldt Klausen, Niklas Dyrby Johansen, Manan Pareek, Daniel Modin, Alexander Mathioudakis, Jørgen Vestbo, Josefin Eklöf, Alexander Jordan, John R. Hurst, Tor Biering-Sørensen, Jens-Ulrik Jensen
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
RationaleLong-acting muscarinic antagonists (LAMAs) reduce the risk of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), usually taken once daily in the morning. However, the circadian activity of autonomic regulation suggests th
Externí odkaz:
https://doaj.org/article/c51d3d562add4c2dbf3ed4d54834c322
Autor:
Peter Kamstrup, Pradeesh Sivapalan, Christian Rønn, Ema Rastoder, Daniel Modin, Anna Kjaer Kristensen, Elisabeth Bendstrup, Rikke Sørensen, Tor Biering-Sørensen, Charlotte Suppli Ulrik, Jørgen Vestbo, Jens-Ulrik Jensen
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Patients with chronic obstructive pulmonary disease (COPD) have a high incidence of cardiovascular disease including thromboembolisms. Fibrin degradation products, like D-dimer, have been associated with death from all causes in h
Externí odkaz:
https://doaj.org/article/22a15c774cd34f1ca0fb4b0d798277b1
Autor:
Sarah Altaraihi, Peter Kamstrup, Josefin Eklöf, Niklas Dyrby Johansen, Tor Biering-Sørensen, Pradeesh Sivapalan, Jens-Ulrik Jensen
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background Venous thromboembolism has been reported in patients with coronavirus disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral anticoagulation, for reasons other than COVID-19, protects against death in patients wi
Externí odkaz:
https://doaj.org/article/0d4e47c0e6c742b097f96f7eb2cca323
Biomarkers in Chronic Obstructive Pulmonary Disease: Emerging Roles of Eosinophils and Procalcitonin
Autor:
Pradeesh Sivapalan, Jens-Ulrik Jensen
Publikováno v:
Journal of Innate Immunity, Pp 1-9 (2021)
Antibiotics can improve the prognosis in patients with exacerbation of chronic obstructive pulmonary disease. However, the overuse of antibiotics can carry serious adverse effects for patients (gastrointestinal infections) and for society (bacterial
Externí odkaz:
https://doaj.org/article/84f4c6604b6d4781a17ade8e0a20fe15
Autor:
Peter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, Nils Hoyer, Charlotte Suppli Ulrik, Lars Pedersen, Therese S. Lapperre, Zitta Barrella Harboe, Uffe Bodtger, Rasmus Dahlin Bojesen, Kjell E.J. Håkansson, Casper Tidemandsen, Karin Armbruster, Andrea Browatzki, Howraman Meteran, Christian Niels Meyer, Kristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Jens D. Lundgren, Tor Biering-Sørensen, Jens-Ulrik Jensen
Publikováno v:
International Journal of Infectious Diseases, Vol 108, Iss , Pp 370-376 (2021)
Objective: Hydroxychloroquine has been proposed as a primary prophylactic agent against coronavirus disease 2019 (COVID-19). This study aimed to investigate if patients treated with hydroxychloroquine for a non-COVID-19 indication had a lower risk of
Externí odkaz:
https://doaj.org/article/6ea3e4eae5cb41fc95e75515211301d9
Autor:
Pradeesh Sivapalan, Jonas Rutishauser, Charlotte Suppli Ulrik, Jörg D. Leuppi, Lars Pedersen, Beat Mueller, Josefin Eklöf, Tor Biering-Sørensen, Vibeke Gottlieb, Karin Armbruster, Julie Janner, Mia Moberg, Therese S. Lapperre, Thyge L. Nielsen, Andrea Browatzki, Alexander Mathioudakis, Jørgen Vestbo, Philipp Schüetz, Jens-Ulrik Jensen
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Systemic corticosteroid administration for severe acute exacerbations of COPD (AECOPD) reduces the duration of hospital stays. Corticosteroid-sparing regimens have showed non-inferiority to higher accumulated dose regimens regardi
Externí odkaz:
https://doaj.org/article/aa7e4ae8c8ea407dbdf032c0bf36fe8c
Autor:
Theis S. Itenov, Daniel I. Sessler, Ashish K. Khanna, Sisse R. Ostrowski, Pär I. Johansson, Christian Erikstrup, Ole B. Pedersen, Sofie L. Rygård, Lars B. Holst, Morten H. Bestle, Lars Hein, Anne Lindhardt, Hami Tousi, Mads H. Andersen, Thomas Mohr, Jens D. Lundgren, Jens-Ulrik Jensen
Publikováno v:
Annals of Intensive Care, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Background We aimed to determine if the ABO blood types carry different risks of 30-day mortality, acute kidney injury (AKI), and endothelial damage in critically ill patients with sepsis. This was a retrospective cohort study of three indep
Externí odkaz:
https://doaj.org/article/6496cd451d274d34837948a1c53d4239
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1395 (2023)
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with distinct phenotypes, each having distinct treatment needs. Eosinophilic airway inflammation is present in a subset of COPD patients in whom it can act as a driver of exacerb
Externí odkaz:
https://doaj.org/article/89538abc2c0847178db1cdcbeb1978f4
Autor:
Pradeesh Sivapalan, Niklas R. Jørgensen, Alexander G. Mathioudakis, Josefin Eklöf, Therese Lapperre, Charlotte Suppli Ulrik, Helle F. Andreassen, Karin Armbruster, Praleene Sivapalan, Julie Janner, Nina Godtfredsen, Ulla M. Weinreich, Thyge L. Nielsen, Niels Seersholm, Torgny Wilcke, Philipp Schuetz, Tobias W. Klausen, Kristoffer Marså, Jørgen Vestbo, Jens-Ulrik Jensen
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Long-term treatment with corticosteroids causes loss of bone density, but the effects of using short-term high-dose systemic-corticosteroid therapy to treat acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are
Externí odkaz:
https://doaj.org/article/bc1187ba20614454bf48856290fbb5a8
Autor:
Najib Rahman, Babu Naidu, Eihab O Bedawi, Zaigham Saghir, Uffe Bodtger, Bo Martin Bibby, Christian B Laursen, Thomas Decker Christensen, Morten Bendixen, Søren Helbo Skaarup, Jens-Ulrik Jensen, Rene Horsleben Petersen, Merete Christensen, Peter Licht, Kirsten Neckelmann, Lars B Møller, Morten Hornemann Borg, Sten Langfeldt, Stefan M W Harders
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Pleural empyema is a frequent disease with a high morbidity and mortality. Current standard treatment includes antibiotics and thoracic ultrasound (TUS)-guided pigtail drainage. Simultaneously with drainage, an intrapleural fibrinolyticu
Externí odkaz:
https://doaj.org/article/4d0488125e834a18b61c640fb2130ea8